Status:

TERMINATED

Effects of High Caffeine Content Coffee on Blood Pressure in Young Adults

Lead Sponsor:

University of Rochester

Conditions:

High Blood Pressure

Eligibility:

All Genders

18-30 years

Phase:

NA

Brief Summary

The purpose of this study is to help further the understanding of the effects of commercially available high-caffeine containing coffee on blood pressure in healthy adult subjects.

Eligibility Criteria

Inclusion

  • Age greater than or equal to 18 years old
  • Male or Female
  • No prior diagnosis of hypertension
  • No prior chronic disease requiring medical intervention
  • Ability to demonstrate correct usage of ambulatory blood pressure monitoring device

Exclusion

  • \- Age less than 18 years old
  • Prior chronic disease (such as hypertension) requiring medical intervention
  • Previously undiagnosed hypertension
  • Intolerance or allergy to coffee or caffeine
  • Inability to demonstrate correct usage of ambulatory blood pressure monitoring device
  • Inability to complete the required abstinence period prior to study interventions
  • Known pregnancy
  • Use of birth control
  • Tobacco use
  • Participation in other investigational drug studies at the time of this study
  • Medical illness requiring medical or symptomatic management

Key Trial Info

Start Date :

December 2 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 19 2019

Estimated Enrollment :

1 Patients enrolled

Trial Details

Trial ID

NCT04060225

Start Date

December 2 2019

End Date

December 19 2019

Last Update

January 14 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

URMC Cardiology; 919 Westfall Rd, Building C

Rochester, New York, United States, 14618